Ohio haemorrhage quality improvement project: initial implementation of the Alliance for Innovation on Maternal Health (AIM) Hemorrhage Patient Safety Bundle Authors: Katherine Jenkins, Allison Lorenz, Michelle C Menegay, Jennifer Fredette, Abigail Ezzeldin, Alyssa Antonini, Justin R Lappen, Patrick Schneider, Dana Mayer, Rashelle Ghanem Published: 2025 ABSTRACT AbstractBackgroundObstetrical haemorrhage is a common complication of childbirth, and all patients are at risk for haemorrhage. Mortality attributable to haemorrhage has been decreasing in the USA, but the incidence of haemorrhage has continued to increase. In Ohio, one-third (31%) of all pregnancy-related deaths in 2020 were due to causes other than infection, mental health or embolisms, with 3% of those attributed to haemorrhage. Haemorrhage was the third leading cause of pregnancy-related death in the state from 2008 to 2016.MethodsSponsored by the Ohio Department of Children and Youth, the Hemorrhage Quality Improvement Project (QIP) applies the Institute for Healthcare Improvement’s methodology to implement structured quality improvement (QI) activities to improve key measures and implement the Alliance for Innovation on Maternal Health’s Obstetric Hemorrhage Patient Safety Bundle. Hospitals provided patient data and completed surveys. Data from participating hospitals were used to calculate and monitor improvement in primary process measures (quantitative blood loss and haemorrhage risk assessment).ResultsAcross Ohio, 22 delivery hospitals spanning 13 health systems participated in the Hemorrhage QIP pilot. Participating hospitals achieved a statistically significant improvement in all process measures, including quantitative blood loss documentation (both overall and when limited to vaginal deliveries) and in the completion of haemorrhage risk assessment between admission and delivery.ConclusionsThe Hemorrhage QIP demonstrates feasibility of a statewide QI initiative to improve care for women who experience obstetrical haemorrhage. Delivery hospitals have clinical expertise to improve outcomes related to postpartum haemorrhage care. Providing opportunity for peer-to-peer learning, evidence-based resources and QI coaching within a replicable QI project creates an opportunity to reduce preventable morbidity and mortality caused by an obstetric haemorrhage.Keywords: Quality improvement, Quality improvement methodologies, Obstetrics and gynecology, PDSA, Maternal Health Services WHAT IS ALREADY KNOWN ON THIS TOPIC Obstetric haemorrhage is a leading cause of severe maternal morbidity and mortality in the USA. Many cases are preventable through earlier recognition and intervention, yet adoption of evidence-based practices such as risk assessment and quantitative blood loss measurement has been inconsistent across hospitals. Obstetric haemorrhage is a leading cause of severe maternal morbidity and mortality in the USA. Many cases are preventable through earlier recognition and intervention, yet adoption of evidence-based practices such as risk assessment and quantitative blood loss measurement has been inconsistent across hospitals. WHAT THIS STUDY ADDS This study shows that a statewide quality improvement pilot across 22 hospitals achieved significant improvements in haemorrhage risk assessment and use of quantitative blood loss measurement. Hospitals also strengthened supportive structures, including policies, supplies, emergency protocols, drills and patient education. This study shows that a statewide quality improvement pilot across 22 hospitals achieved significant improvements in haemorrhage risk assessment and use of quantitative blood loss measurement. Hospitals also strengthened supportive structures, including policies, supplies, emergency protocols, drills and patient education. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Implementing a statewide collaborative model with coaching, data feedback and peer learning can improve critical processes of haemorrhage care. While the long-term impact on outcomes is still uncertain, these findings support continued investment in collaboratives and measurement infrastructure to sustain improvements, evaluate effectiveness and advance equity in maternal health. Implementing a statewide collaborative model with coaching, data feedback and peer learning can improve critical processes of haemorrhage care. While the long-term impact on outcomes is still uncertain, these findings support continued investment in collaboratives and measurement infrastructure to sustain improvements, evaluate effectiveness and advance equity in maternal health. Introduction Women experience substantial health and safety risks throughout the pregnancy, delivery and the postpartum period, including severe maternal morbidity (SMM) and pregnancy-related death. It is estimated that for every pregnancy-related death, another 100 patients experience SMM.1 SMM increased 75% in the USA over the past decade and is estimated to affect 163 of every 10 000 deliveries in Ohio annually.2 There were 22 pregnancy-related deaths due to haemorrhage from 2008 to 2016 in Ohio, demonstrating this need for improvement in postpartum haemorrhage (PPH) care.2 Some groups of women are more likely to experience adverse events, including those who are of advanced maternal age, who are enrolled in Medicaid or uninsured or who are Hispanic or non-Hispanic black.3 In Ohio, from 2008 to 2016, non-Hispanic black women were more than 2.5 times more likely to die from pregnancy-related causes than non-Hispanic white women, 4 with haemorrhage identified as the third leading cause of pregnancy-related death.2 In 2020, 66% of pregnancy-related deaths were preventable.5 PPH refers to excessive blood loss after the delivery of the placenta. PPH complicates approximately 4% of vaginal deliveries and 6–7% of caesarean deliveries.1 Internationally, the WHO defines PPH as blood loss of ≥500 mL within 24 hours of birth, recognising this threshold as clinically significant.6 In the USA, the reVITALize Obstetric Data Definitions classify PPH as ≥1000 mL of cumulative blood loss or blood loss accompanied by signs or symptoms of hypovolaemia, regardless of delivery route.7 While blood loss between 500 mL and 999 mL may not meet the US definition of PPH, it is still considered potentially abnormal and should prompt evaluation and appropriate clinical management.7 Historically, blood loss at delivery was underestimated due to reliance on a non-quantitative approach (visual inspection/estimation), which has significant interobserver variability.1 Additionally, pregnancy-related physiological changes to vital signs may mask typical changes that occur with haemorrhage until someone has more significant blood loss/hypovolaemia (such as increased heart rate, decreased blood pressure). As such, an excessive amount of blood loss may not be recognised before a significant worsening in the maternal condition is evident. Quantitative measurement of blood loss is a newer, standardised approach to blood loss calculation at delivery, which may improve recognition and early intervention for PPH; however, this methodology has not been widely adopted, leaving opportunity for improvements in care processes. Project background The Maternal Safety Quality Improvement Project (MSQIP), sponsored by the Ohio Department of Children and Youth, using funding from the Health Resources Services Administration, and administered by The Ohio Colleges of Medicine Government Resource Center in partnership with The Ohio State University Wexner Medical Centre, the Cleveland Clinic Foundation and the Ohio Hospital Association, was implemented beginning in October 2022. The Alliance for Innovation on Maternal Health (AIM) Hemorrhage Patient Safety Bundle provides actionable steps that can be adapted into change package resources for quality improvement (QI) for a variety of facilities to improve quality of care and outcomes for patients experiencing an obstetric haemorrhage through the 5Rs for implementation (readiness, recognition and prevention, response, reporting and systems learning and respectful care).6 A planning period for the Ohio Hemorrhage Quality Improvement ProjectQuality Improvement Project (QIP) began in January 2022, led by an interdisciplinary clinical advisory panel comprised of maternal fetal medicine subspecialists, obstetrics and gynaecology specialists, QI experts, researchers and state sponsor representatives. Three of the clinical advisory panel subject matter experts had experience implementing the AIM hypertension bundle in Ohio, with an additional four QI experts bringing extensive experience in leading effective statewide QI collaboratives and coaching clinical teams.8 This team identified the primary clinical objectives for the Hemorrhage QIP which focused on improving the proportion of women who are at risk of/experienced a haemorrhage who receive: appropriate risk assessment, measurement of quantified blood loss (QBL) at delivery, verbal debriefing of obstetrical haemorrhage events and multidisciplinary case review.9 Additional data were tracked on unit drills related to haemorrhage and completion of provider education and nursing education on respectful and equitable care. These core clinical and educational processes were identified by the project team as critical interventions needed to reduce adverse events associated with haemorrhage and health disparities related to haemorrhage during pregnancy or in the postpartum period by 2026. The clinical advisory panel engaged in the design process for the Hemorrhage QIP by structuring the clinical change package around the 5R domains outlined in the AIM patient safety bundles.7 9 The resources available within these domains included: processes for management of obstetrical haemorrhage, including but not limited to, designating a rapid response team, standardised checklists and escalation policies, emergency release and massive transfusion protocols, maintaining a haemorrhage cart, access to medication, team base drills and debriefs, appropriate risk assessments, utilisation of QBL, active management of third stage of labour, patient education and multidisciplinary review of serious complications. Across all these resources, the project team sought to reinforce patient and family engagement and affirm empathetic communication. Methods The MSQIP collaborative used an adapted version of the Institute for Healthcare Improvement Model for Improvement, which includes establishing Specific-Measurable-Attainable-Relevant-Timebound (SMART) aims, defining measures and identifying tests of change via the implementation of Plan-Do-Study-Act (PDSA) cycles. The Hemorrhage QIP has three identified SMART aims: (1) increase the percentage of mothers who had a haemorrhage risk assessment with risk level assigned to >95% by September 2025; (2) increase the percentage of hospitals using QBL for vaginal deliveries to 78% by September 2025 and (3) increase the percentage of hospitals using QBL for caesarean deliveries to 87.5% by September 2025. Study population The pilot of the Hemorrhage QIP identified 22 maternity hospitals to participate across 13 different health systems. Hospitals were prioritised for engagement based on patient volume and provision of high-risk obstetrical services. Hospitals were tasked with identifying a multidisciplinary team including but at minimum a maternal fetal medicine subspecialist or obstetrics and gynaecology specialist to serve as the clinical champion, a QI lead and additional nursing and administrative support. Team composition varied by health system and hospital patient volume. Patients and the public were not involved in any way in this pilot Hemorrhage QIP. QI activities Participating hospitals engaged in an onboarding webinar with their health system, collaborative monthly webinars and quarterly hospital-specific QI coaching calls. Collaborative monthly webinars presented opportunities for peer-to-peer learning to discuss clinical best practices, review data and share barriers to care. A comprehensive list of clinical topics is available in online supplemental appendix A. Each health system was provided a minor monetary stipend to support staff time required for meeting attendance and data reporting. Active implementation for the pilot began in October 2022 and concluded in April 2024. The quarterly hospital-specific QI coaching calls and implementation of PDSA cycles for process and system improvements were fundamental components of project activities for the haemorrhage QIP. A QI coach met quarterly with all hospitals to review data measures in the QI dashboard, discuss priorities and identify small tests of change. The project team reviewed progress on project measures to date in real time, drawing attention to notable patterns that could then guide future action and potential PDSAs. Coaching calls were primarily held individually, with select larger systems opting to meet in a group setting to discuss and work through testing together. Of the 13 health systems involved, 11 (n=13 hospitals) worked on QBL PDSAs. QBL PDSAs varied by hospital based on their workflows and starting points. Teams tested small changes over multiple cycles, such as piloting QBL documentation in a single provider before spreading to the entire unit. For example, one hospital trialled the use of the Electronic Health Record (EHR) tool ‘Hemorrhage Narrator’ for two PDSA cycles, first testing feasibility on a small scale and then adapting the process through staff education and practice-day reinforcement before broader implementation. Other tested interventions in the pilot project can be found in online supplemental appendix D. Data (measures) and data collection (sources) The Hemorrhage QIP collected data through an annual needs assessment survey (administered via Qualtrics) and a quarterly data collection form (administered via REDCap). The needs assessment survey focused on structure measures at the hospital level and consisted of 17 substantive subject-area questions meant to generate a snapshot of each hospital’s level of engagement with the matter of obstetrical haemorrhage (online supplemental appendix B). These questions were sourced from the AIM’s structure measures and included such topics as: patient debriefs after a severe event, multidisciplinary systems-level reviews on cases of SMM, the availability of haemorrhage supplies in a cart or mobile box, use of simulation training and the availability of resources and supplies to quantify cumulative blood loss. A full list of measures for the Hemorrhage QIP can be found in tables1 2. Table 1Ohio Alliance for Innovation in Maternal Health Obstetric Hemorrhage Quality Improvement Project outcome, process and structure measuresMeasure definitionNumeratorDenominatorOutcome measures HaemorrhageNumber of pregnant and postpartum people with documented blood loss of ≥1000 mL this monthTotal number of people giving birth (≥20 0/7 weeks gestation) Massive transfusionNumber of pregnant and postpartum people who had ≥4 units of packed red blood cells transfused this monthTotal number of people giving birth (≥20 0/7 weeks gestation)Process measures Risk assessmentNumber of birth admissions that had a haemorrhage risk assessment completed with risk level assigned, performed at least once between admission and birthAll birth admissions, whether from sample or entire population Quantified blood lossNumber of birth admissions that had measurement of blood loss from birth through the recovery period using quantitative and cumulative techniquesAll birth admissions, whether from sample or entire population Patient support after obstetric haemorrhage*Among the denominator, those who received a verbal briefing on their obstetric haemorrhage by their care team before discharge.Pregnant and postpartum people with ≥1000 mL blood loss during the birth admission Multidisciplinary case reviewNumber of completed structured case reviews among those in the denominatorTotal number of pregnant and postpartum patients with blood loss ≥1000 mL and either ≥4 units of packed red blood cells transfused or admission to ICU during birth admissionStructure measures Unplanned hysterectomiesNumber of people who had an unplanned hysterectomy this monthTotal number of people giving birth (≥20 0/7 weeks gestation)*Some hospitals expressed concern that conducting a verbal briefing with patients after obstetric haemorrhage could be construed as an admission of liability. Clinical leads addressed this topic in an Action Period (AP) call. Due to continued uncertainty on the part of some hospitals, the patient support after obstetric haemorrhage measure became optional at the start of quarter 3, and data submission rates for this measure fell.ICU, intensive care unit. Ohio Alliance for Innovation in Maternal Health Obstetric Hemorrhage Quality Improvement Project outcome, process and structure measures Some hospitals expressed concern that conducting a verbal briefing with patients after obstetric haemorrhage could be construed as an admission of liability. Clinical leads addressed this topic in an Action Period (AP) call. Due to continued uncertainty on the part of some hospitals, the patient support after obstetric haemorrhage measure became optional at the start of quarter 3, and data submission rates for this measure fell. ICU, intensive care unit. Table 2Ohio AIM Obstetric Hemorrhage Quality Improvement Project annual process and structure measuresMeasure definitionMeasure descriptionProcess measures Unit drillsP1a: In this quarter, how many OB drills (In Situ and/or Sim Lab) were performed on your unit for any maternal safety topic?P1b: In this quarter, what topics were covered in the OB drills? Provider educationP2a: OB provider education on obstetric haemorrhage. At the end of this reporting period, what cumulative proportion of OB physicians and midwives has completed within the last 2 years an education programme on obstetric haemorrhage that includes the unit: standard protocols and procedures? P2b: OB provider education on respectful and equitable care. At the end of this reporting period, what cumulative proportion of OB physicians and midwives has completed within the last 2 years an education programme on respectful and equitable care? Nursing educationP3a: OB nursing education on obstetric haemorrhage. At the end of this reporting period, what cumulative proportion of OB nurses (including L&D and postpartum) has completed within the last 2 years an education programme on obstetric haemorrhage that includes the unit - standard protocols and measures? P3b: OB nursing education on respectful and equitable care. At the end of this reporting period, what cumulative proportion of OB nursing staff (including L&D and postpartum) has completed within the last 2 years an education programme on respectful and equitable care?Structure measures Patient event debriefsHas your department established a standardised process to conduct debriefs with patients after a severe event? Debriefs (system level)Has your department established a system to perform regular formal debriefs with the clinical team after cases with major complications? Multidisciplinary case reviewsHas your hospital established a process to perform multidisciplinary systems-level reviews on cases of severe maternal morbidity (including, at a minimum, birthing patients admitted to the ICU or receiving ≥4 units RBC transfusions? Haemorrhage cartDoes your hospital have obstetric haemorrhage supplies readily available in a cart or mobile box? Unit policy and procedureDoes your hospital have obstetric haemorrhage policies and procedures (reviewed and updated in the last 2 years) that contain the following:S5a: an obstetric rapid response team appropriate to the facility’s maternal level of careS5b: a standardised, stage based, obstetric haemorrhage emergency management plan with checklists and escalation policyS5c: emergency release and massive transfusions protocolsS5d: a protocol for patients who decline blood products but may accept alternative approachesAIM, Alliance for Innovation on Maternal Health; ICU, intensive care unit ; L&D, Labor and Delivery; OB, Obstetric ; P, Process Measure; RBC, red blood cell; S, Structure Measure. Ohio AIM Obstetric Hemorrhage Quality Improvement Project annual process and structure measures AIM, Alliance for Innovation on Maternal Health; ICU, intensive care unit ; L&D, Labor and Delivery; OB, Obstetric ; P, Process Measure; RBC, red blood cell; S, Structure Measure. The quarterly data collection form consisted of three components: (1) aggregate patient data, (2) data on obstetric drills and (3) chart review of 30 randomised patients (20 vaginal deliveries and 10 caesarean deliveries). Hospitals with fewer than 20 vaginal deliveries or 10 C-section deliveries per month reviewed all relevant charts during the specified periods. The first component of the data form, the aggregate patient data, requested counts of all births as well as counts of pregnant and postpartum people with documented haemorrhage (defined throughout the data form as documented blood loss ≥1000 mL), transfusion of ≥ four units of packed red blood cells and unplanned hysterectomy. These four measures were all stratified by mode of delivery and patient race/ethnicity. A final pair of aggregate patient data measures included the count of instances of haemorrhage combined with either transfusion or admission to the intensive care unit (ICU) during birth admission and the count of structured case reviews completed for these instances of combined haemorrhage-transfusion or haemorrhage-ICU admission. The second component of the data form, quarterly data on obstetric drills, required the count of drills, ‘in Situ and/or Sim Lab,’ that were performed for obstetric haemorrhage. A subsequent free-response question asked hospitals to then list the topics that had been covered in their obstetric drills. Lastly, the third component of the data form required two counts, obtained through random chart review and displayed by mode of delivery: first, the count of reviewed charts that indicated completion of a risk assessment along with the assignment of a risk level between admission and birth; second, the count of reviewed charts that documented quantitative blood loss. An example of the quarterly data collection form (that does not include the structure measures that needed to be included in one quarter to account for AIM’s updates to its structure measures) can be found in online supplemental appendix C. Initial data were uploaded to a secure REDCap data portal; data were then displayed via a secure, R-Shiny data dashboard, which could be viewed in a deidentified manner by participating hospitals and included multiple data visualisations and stratification viewpoints. The project dashboard displayed bar charts for the outcome measures of obstetric haemorrhage, massive transfusion and unplanned hysterectomies; the process measures of risk assessment, QBL, multidisciplinary case review and obstetric haemorrhage drills. These measures were able to be examined by patient race/ethnicity, delivery method, maternity care level and whether a hospital was in a rural or urban county. Additionally, the project dashboard included run charts for all measures, which could be displayed on a monthly, quarterly or yearly timeframe. These run charts visualised overall measure progress over time; they also provided users with the ability to compare and stratify results within a measure in three ways: (1) between other participating hospitals within their own health system (2) by the hospital characteristics of maternity care level and urban versus rural and (3) by the patient characteristics of race/ethnicity and delivery method. Finally, hospitals could recalculate the median for a run chart based on The Health Care Data Guide’s rule for a shift (six or more consecutive points all sitting above or below the median line) or a trend (five or more consecutive points, all moving up or down).10 As of December 2023, data were transferred to a new dashboard hosted through the Ohio Hospital Association to support sustainable improvement activities. Statistical analysis Using hospital data, we conducted descriptive statistics to identify demographic and delivery characteristics of the patient population (online supplemental appendix E). Baseline medians were calculated using data from 3 months prior to implementation. After the first year of project implementation, we conducted two-sample z-tests to assess for differences in baseline and post implementation medians for each measure with sufficient cell size (denominator ≥30 and numerator ≥10). We analysed the structure measures from the annual needs assessment to identify changes in hospital policies and practices. All analyses were conducted using R V.4.4.0. The state department institutional review board deemed this project exempt. Results Overall, 29 hospitals were recruited to participate in the haemorrhage QIP pilot, with 22 completing activities for the full year. Among the 22 hospitals, there were 44 213 pregnant patients delivering at or beyond 20 weeks of gestation, with 3651 (8.3%) diagnosed with a PPH (blood loss ≥1000 mL). The median percentage of pregnant people diagnosed with haemorrhage increased from 7.6% at baseline to 8.3% at the end of the first year of implementation (online supplemental appendix F). In the 22 participating hospitals, there were 7868 sampled birth admissions and of those 7104 (90.3%) had a risk assessment performed at least once between admission and birth. Haemorrhage risk assessment improved from a baseline median of 82% to a median of 92.4% at the end of the first year of the project (online supplemental appendix F), and this change was statistically significant. For the process measure of use of QBL, 72.5% (5702 of 7868 sampled birth admissions) used quantitative and cumulative measurement techniques to monitor blood loss. The use of QBL among both modes of delivery increased from a baseline median of 66.6% to a median of 73.0% at the end of the first project year (online supplemental appendix F, figure 1) with a statistically significant improvement for vaginal deliveries only (9.0% increase) (figures2 3, online supplemental appendix F). These measures all showed significant improvement, which indicates progress toward the overall Hemorrhage QIP SMART aims. Aggregate measurement of blood loss using quantitative and cumulative techniques for all Wave 1 sites. Run chart showing the aggregate percentage of sampled birth admissions that had measurement of blood loss from birth through the recovery period using quantitative and cumulative techniques for all participating hospital sites in Wave 1 of the Hemorrhage QIP. Chart includes the median line calculated from baseline (July 2022–September 2022) and includes one special cause shift in the desired direction. QBL, quantified blood loss; QIP, quality improvement project. Quantitative blood loss for birth admissions delivered by caesarean section. Run chart showing the aggregate percentage of sampled birth admissions delivered by caesarean section that had measurement of blood loss from birth through the recovery period using quantitative and cumulative techniques for all participating hospital sites in Wave 1 of the Hemorrhage QIP. Chart includes the median line calculated from baseline (July 2022 – September 2022) and includes one special cause shift in the desired direction. QBL, quantified blood loss; QIP, quality improvement projecQuality Improvement Project. Quantitative blood loss for birth admissions delivered vaginally. Run chart showing the aggregate percentage of sampled birth admissions delivered vaginally that had measurement of blood loss from birth through the recovery period using quantitative and cumulative techniques for all participating hospital sites in wave 1 of the haemorrhage QIP. Chart includes the median line calculated from baseline (July 2022 – September 2022) and includes one special cause shift in the desired direction. QBL, quantified blood loss; QIP, quality improvement projecQuality Improvement Project. Many participating delivery hospitals have a foundation from previous work on haemorrhage patient safety, with 68% indicating on the needs assessment they had already implemented components of the AIM haemorrhage bundle and 100% of hospitals responding that they had haemorrhage policies and procedures currently in place. Of the 22 participating hospitals, 20 completed both preneeds and post needs assessments. Positive progress change was observed for all structure measures related to hospital policies (online supplemental appendix G). After participating in the QIP, 85% of hospitals reported having resources and supplies available to quantify blood loss fully in place and the remaining 15% were in progress. Additionally, 100% of hospitals had developed patient education materials on urgent maternal warning signs, a standardised obstetric emergency management plan and had emergency release and massive transfusion protocols fully in place. As participating hospitals work to update their policies and procedures according to the best practice clinical change package, they shared barriers and successes on monthly collaborative calls through presentations of hospital level data showing successful improvements, outlining how they adapted PDSAs after failure and ultimately made improvements over time. Clinical and research implications In our multi-institution QIP focused on obstetrical haemorrhage, we demonstrated significant improvements in important clinical process measures, including risk-stratification and the implementation and utilisation of QBL in haemorrhage. These findings are notable as they support the use of interdisciplinary and multimodal QI work in large-scale improvements in obstetric care processes. Our work largely mirrors published literature on PPH, which has demonstrated that implementation of standardised, haemorrhage-specific protocols results in improved care processes related to the management of haemorrhage.10,12 Similar to other single institution studies and quality collaboratives, our study demonstrated a significant increase in the utilisation of QBL.13 A substantial body of published literature has demonstrated that QBL methods of measuring obstetric blood loss are more accurate than visual estimation and that visual estimation underestimates actual blood loss.14,16 With increasing use of quantitative measurement of blood loss, we observed a significant increase in the diagnosis of PPH, which is similar to other published reports of QBL implementation.15 Moreover, QBL documentation for vaginal delivery significantly increased, likely due to hospitals not previously implementing workflows for appropriate determination as compared with caesarean delivery where such workflows already existed. A limitation of our study is that we are not yet able to assess if the use of QBL meaningfully impacted outcomes in patients experiencing haemorrhage, including timeliness of interventions, blood product transfusion or SMM. While data on the impact of QBL utilisation on clinical outcomes remains inconclusive, accurately diagnosing PPH is important for preparation, readiness and timely treatment for all birthing facilities. We also demonstrated a significant increase in haemorrhage risk stratification by participating hospitals. While use of an evidence-based haemorrhage risk assessment is required by the Joint Commission, a recent systematic review of 14 risk-assessment models concluded that none were sufficiently validated in a general obstetric population.17 Existing PPH risk-assessment tools may have limited predictive accuracy as most high-risk patients do not experience significant haemorrhage and many patients without risk factors experience severe PPH. However, routine utilisation of a tool increases readiness and recognition for an entire unit, which may improve care processes for any patient experiencing PPH. While our study demonstrated an increase in haemorrhage risk assessment, additional time will be needed to assess if risk stratification impacted clinical outcomes in our participating hospitals. Lastly, while we demonstrated improvements in clinical process measures related to haemorrhage management, this initial assessment cannot address the sustainability of the findings over time and if they will translate into improved patient outcomes and reduced haemorrhage-related morbidity and mortality. Strengths and limitations The strengths of our study include the replication of a QI model previously shown to have impactful results in Ohio’s labour and delivery hospitals, allowing for teams to build on previous knowledge to accelerate change.10 The Hemorrhage QIP is built on existing haemorrhage approaches/infrastructure (QBL methodology, haemorrhage policies and procedures, risk assessment administration), has standardised data collection and robust QI support to facilitate improvements through specific PDSAs. The limitations of our findings include that all data were self-reported by hospitals and lacked ability to include patient level data based on small sample sizes at the hospital level. The data collection lacked haemorrhage aetiologies and pertinent patient-level outcomes. This limited our ability to assess events like transfer of care to higher-level institutions, but hospitals did receive materials to sufficiently structure workflows to ensure that when such situations arose, they could be adequately managed. In addition to participating hospitals submitting self-reported data, the Hemorrhage QIP is also leveraging historically submitted data to project partners like the Ohio Hospital Association who are collecting state level SMM data. We could not control for other concomitant QI-related work occurring at individual institutions that may have impacted outcomes for this project. Lastly, while other states have implemented the AIM Hemorrhage Bundle, it is unclear how the state’s outcomes compare based on limited published results. Conclusions The Hemorrhage QIP demonstrates the feasibility of a statewide QI initiative to address process measures for SMM related to haemorrhage. Providing an opportunity for peer-to-peer learning between clinical experts, evidence-based resources and QI coaching within a replicable QI project creates an opportunity to positively impact preventable morbidity and mortality from obstetric haemorrhage. Statewide expansion to additional delivery hospitals will follow this initial pilot sponsored by the Ohio Department of Children and Youth. Supplementary material Footnotes Funding: This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totalling $8 288 888 and an award totalling $7 670 233 with 0% percentage financed with non-governmental sources (Grant Number: 5 U7AMC50515-02-00). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the US Government. Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Patient and public involvement: Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research. Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information. References Associated Data Supplementary Materials Data Availability Statement All data relevant to the study are included in the article or uploaded as supplementary information.